Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.
Mendoza N, Ramírez I, de la Viuda E, Coronado P, Baquedano L, Llaneza P, Nieto V, Otero B, Sánchez-Méndez S, de Frutos VÁ, Andraca L, Barriga P, Benítez Z, Bombas T, Cancelo MJ, Cano A, Branco CC, Correa M, Doval JL, Fasero M, Fiol G, Garello NC, Genazzani AR, Gómez AI, Gómez MÁ, González S, Goulis DG, Guinot M, Hernández LR, Herrero S, Iglesias E, Jurado AR, Lete I, Lubián D, Martínez M, Nieto A, Nieto L, Palacios S, Pedreira M, Pérez-Campos E, Plá MJ, Presa J, Quereda F, Ribes M, Romero P, Roca B, Sánchez-Capilla A, Sánchez-Borrego R, Santaballa A, Santamaría A, Simoncini T, Tinahones F, Calaf J. Mendoza N, et al. Among authors: de la viuda e. Maturitas. 2022 Dec;166:65-85. doi: 10.1016/j.maturitas.2022.08.008. Epub 2022 Aug 30. Maturitas. 2022. PMID: 36081216
Continuation rate of combined hormonal contraception: a prospective multicenter study.
Lete I, Pérez-Campos E, Correa M, Robledo J, de la Viuda E, Martínez T, Mendoza N, Parera N, González JV, Gómez MA, Castelo-Branco C, Lobo P. Lete I, et al. Among authors: de la viuda e. J Womens Health (Larchmt). 2012 May;21(5):490-5. doi: 10.1089/jwh.2011.2967. Epub 2011 Oct 26. J Womens Health (Larchmt). 2012. PMID: 22029626
Effect on quality of life of switching to combined oral contraception based on natural estrogen: an observational, multicentre, prospective phase IV study (ZOCAL Study).
Lete I, de la Viuda E, Pérez-Campos E, Martínez MÁ, Sanchez-de la Rosa R, Novalbos J, Sánchez-Borrego R. Lete I, et al. Among authors: de la viuda e. Eur J Contracept Reprod Health Care. 2016 Aug;21(4):276-84. doi: 10.3109/13625187.2016.1174206. Epub 2016 May 25. Eur J Contracept Reprod Health Care. 2016. PMID: 27220697 Clinical Trial.
Cross-sectional evaluation of the impact of information on flexible extended regimens of oral contraceptives in the choices made by women seeking contraceptive counselling: the FLEXO study.
Lete I, Calleja J, Pérez-Campos E, de la Viuda E, Lertxundi R, Martínez M, Quesada M, Sánchez-Borrego R. Lete I, et al. Among authors: de la viuda e. Eur J Contracept Reprod Health Care. 2018 Aug;23(4):260-264. doi: 10.1080/13625187.2018.1493099. Epub 2018 Sep 11. Eur J Contracept Reprod Health Care. 2018. PMID: 30203678
Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia.
Ramírez I, De la Viuda E, Baquedano L, Coronado P, Llaneza P, Mendoza N, Otero B, Sánchez S, Cancelo MJ, Páramo JA, Cano A. Ramírez I, et al. Among authors: de la viuda e. Maturitas. 2020 Jul;137:57-62. doi: 10.1016/j.maturitas.2020.04.019. Epub 2020 May 6. Maturitas. 2020. PMID: 32498938 Free PMC article.
19 results